Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes: Evidence in a rabbit ear dermal ulcer model

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2462-2468

  Galiano, Robert D ^a   Zhao, Lily L ^a   Clemmons, David R ^b   Roth, Sanford I ^a   Lin, Xuanhan ^a   Mustoe, Thomas A ^a,c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Div of Plast and Reconstr Surgery   (United States)

Author keywords

extracellular matrix; growth factors; insulin like growth factor I; integrins; wound healing

Indexed keywords

BINDING PROTEIN; GROWTH FACTOR RECEPTOR; INTEGRIN; SOMATOMEDIN B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EPITHELIZATION; EXTRACELLULAR MATRIX; GRANULATION TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; RABBIT; SKIN FIBROBLAST; TISSUE REPAIR; WOUND HEALING;

EID: 0029826177     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119064     Document Type: Article

References (57)

1. Mustoe, T.A., and R.D. Galiano. 1993. Mediators of wound healing, including the role of growth factors. In Advances in Wound Healing and Tissue Repair. Vol. 4. R.C. Lee, T.A. Mustoe, and J.W. Siebert, editors. World Medical Press, New York. 27-55.
2. Jyung, R.W., and T.A. Mustoe. 1993. Role of cytokines in wound repair. In Clinical Applications of Cytokines. A. Gearting, J. Rossio, and J. Oppenheim, editors. Oxford University, New York. 307-329.
3. Rapraeger, A.C., A. Krufka, and B.B. Olwin. 1991. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science (Wash. DC). 252:1705-1707.
4. Ruoslahti, E., and Y. Yamaguchi. 1991. Proteoglycans as modulators of growth factor activities. Cell. 64:867-869.
5. Ruoslahti, E., Y. Yamaguchi, A. Hildebrand, and W.A. Border. 1992. Extracellular matrix/growth factor interactions. Cold Spring Harbor Svyp. Quant. Biol. 57:309-315.
6. Lopez-Casillas, F., H.M. Payne, J.L. Andres, and J. Massague. 1994. Betaglycan can act as a dual modulator of TGF-β access to signaling receptors. Mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124:557-568.
7. Adams, J.C., and F.M. Watt. 1993. Regulation of development and differentiation by the extracellular matrix. Development (Cambridge). 117:1183-1198.
8. Streuli, C.H., C. Schmidhauser, M. Kobrin, M.J. Bissell, and R. Derynck. 1993. Extracellular matrix regulates expression of the TGF-β1 gene. J. Cell Biol. 120:253-260.
9. Skottner, A., M. Kanje, E. Jennische, J. Sjögren, and L. Fryklund. 1988. Tissue repair and IGF-I. Acta Paediatr. Scand. 347(Suppl.):110-112.
10. Steenfos, H.H., and J.Q. Janssen. 1992. Gene expression of insulin-like growth factor-I and IGF-I receptor during wound healing in rats. Eur. J. Surg. 158:327-331.
11. Gartner, M.H., J.D. Benson, and M.D. Caldwell. 1992. Insulin-like growth factors I and II expression in the healing wound. J. Surg. Res. 52:389-394.
12. Suh, D.Y., T.K. Hunt, and E.M. Spencer. 1992. Insulin-like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology. 131:2399-2403.
13. Clemmons, D. R. 1992. IGF binding proteins: regulation of cellular actions. Growth Regul. 2:80-87.
14. Rechler, M.M., and A.L. Brown. 1992. Insulin-like growth factor binding proteins: gene structure and expression. Growth Regul. 2:55-68.
15. Jones, J.I., and D.R. Clemmons. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:3-34.
16. Jones, J.I., A. Gockerman, W.H. Busby, G. Wright, and D.R. Clemmons. 1993. Insulin-like growth factor binding protein-1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA. 90:10553-10557.
17. Ross, M., G.L. Francis, L. Szabo, J.C. Wallace, and F.J. Ballard. 1989. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-I and IGF-II but not des(1-3)IGF-I. Biochem. J. 258:267-272.
18. Bar, R.S., B.A. Booth, M. Bowes, and B.L. Drake. 1989. Insulin-like growth factor binding proteins from cultured endothelial cells: purification, characterization and intrinsic biologic activities. Endocrinology. 125:1910-1920.
19. Bourner, M.J., W.H. Busby, N.R. Seigel, G.G. Krivi, R.H. McCusker, and D.R. Clemmons. 1992. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J. Cell. Biochem. 48:215-226.
20. Clark, E.A., and J.S. Brugge. 1995. Integrins and signal transduction pathways: the road taken. Science (Wash. DC). 268:233-239.
21. Juhasz, I., G.F. Murphy, H.C. Yan, M. Herlyn, and S.M. Albelda. 1993. Regulation of extracellular matrix proteins and integrin cell substratum adhesion receptors on epithelium during cutaneous human wound healing in vivo. Am. J. Pathol. 143:1458-1469.
22. Gailit, J., and R.A.F. Clark. 1994. Wound repair in the context of extracellular matrix. Curr Opin. Cell Biol. 6:717-725.
23. Larjava, H., T. Salo, K. Haapasalmi, R.H. Kramer, and J. Heino. 1993. Expression of integrins and basement membrane components by wound keratinocytes. J. Clin. Invest. 92:1425-1435.
24. Cavani, A., G. Zambruno, A. Marconi, V. Manca, M. Marchetti, and A. Giannetti. 1993. Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J. Invest. Dermatol. 101:600-604.
25. Zambruno, G., P.C. Marchisio, A. Marconi, C. Vaschieri, A. Melchiori, A. Giannetti, and M. De Luca. 1995. Transforming growth factor-β1 modulates β1 and β5 integrin receptors and induces the de novo expression of the αvβ6 heterodimer in normal human keratinocytes. Implications for wound healing. J. Cell Biol. 129:853-865.
26. Danilenko, D.M., B.D. Ring, J.Z. Lu, J.E. Tarpley, D. Chang, N. Liu, D. Wen, and G.F. Pierce. 1995. Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds. J. Clin. Invest. 95:842-851.
27. Gailit, J., M.P. Welch, and R.A.F. Clark. 1994. TGF-beta1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J. Invest. Dermatol. 103:221-227.
28. Jyung, R.W., T.A. Mustoe, W.H. Busby, and D.R. Clemmons. 1994. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery (St. Louis). 115:233-239.
29. Zhao, L.L., R.D. Galiano, G.N. Cox, S.I. Roth, and T.A. Mustoe. 1995. Effects of insulin-like growth factor-I and insulin-like growth factor binding protein-1 on wound healing in a dermal ulcer model. Wound Repair Regen. 3: 316-321.
30. Carlsson-Skwirut, C., M. Lake, M. Hartmanis, K. Hall, and V.R. Sara. 1989. A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor I (IGF-I). Biochim. Biophys. Acta. 1011: 192-197.
31. Clemmons, D.R., M.L. Dehoff, W.H. Busby, M.L. Bayne, and M.A. Cascieri. 1992. Competition for binding to insulin-like growth factor (IGF) binding protein-2, 3, 4, and 5 by the IGFs and IGF analogs. Endocrinology. 131:890-895.
32. Oh, Y., H.L. Muller, D.Y. Lee, P.J. Fielder, and R.G. Rosenfeld. 1993. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs. Endocrinology. 132:1337-1344.
33. Mustoe, T.A., G.F. Pierce, C. Morishima, and T.F. Deuel. 1991. Growth factor-induced acceleration of tissue repair through direct and inductive activities in a rabbit dermal ulcer model. J. Clin. Invest. 87:694-703.
34. Pierce, G.F., J.E. Tarpley, D. Yanagihara, T.A. Mustoe, G.M. Fox, and A. Thomason. 1992. Platelet-derived growth factor (BB homodimer), transforming growth factor-b1 and basic fibroblast growth factor in dermal wound healing. Am. J. Pathol. 140:1375-1388.
35. Zhao, L., J. Davidson, S. Wee, S. Roth, and T. Mustoe. 1994. Effect of hyperbaric oxygen and growth factors on rabbit ear ischemic ulcers. Arch Surg. 129:1043-1049.
36. Elgin, R.G., W.H. Busby, and D.R. Clemmons. 1987. An insulin-like growth factor (IGF) binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. USA. 84:3254-3258.
37. DeMellow, J.S.M., and R.C. Baxter. 1988. Growth hormone dependent insulin-like growth factor binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in skin fibroblasts. Biochem. Biophys. Res. Commun. 156:199-204.
38. Blum, W.F., E.W. Jenne, F. Reppin, K. Kietzmann, M.B. Ranke, and J.R. Bierich. 1989. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology. 125:766-772.
39. Kratz, G., M. Lake, K. Ljungstrom, G. Forsberg, A. Haegerstrand, and M. Gidlund. 1992. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp. Cell Res. 202:381-385.
40. McCusker, R.H., W.H. Busby, M.H. Dehoff, C. Camacho-Hubner, and D.R. Clemmons. 1991. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology. 129:939-949.
41. Conover, C.A., M. Ronk, F. Lombana, and D.R. Powell. 1990. Structural and biological characterization of bovine insulin-like growth factor binding protein-3. Endocrinology. 127:2795-2803.
42. Blat, C., J. Villaudy, and M. Binoux. 1994. In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. J. Clin. Invest. 93:2286-2290.
43. McCusker, R.H., C. Camacho-Hubner, M.L. Bayne, M.A. Cascieri, and D.R. Clemmons. 1990. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J. Cell. Physiol. 144:244-253.
44. Hamon, G.A., T.K. Hunt, and E.M. Spencer. 1993. In vivo effects of systemic insulin-like growth factor-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul. 3: 53-56.
45. Sommer, A., C.A. Maack, S.K. Spratt, D. Mascarenhas, T.J. Tressel, E.T. Rhodes, R. Lee, M. Roumas, G.P. Tatsuno, J.A. Flynn, et al. 1991. Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3. In Modern Concepts of insulin-like Growth Factors. E.M. Spencer, editor. Elsevier, New York. 715-728.
46. Jones, J.I., A.J. D'Ercole, C. Camacho-Hubner, and D.R. Clemmons. 1991. Phosphorylation of insulin-like growth factor (IGF) binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc. Natl. Acad. Sci. USA. 88:7481-7485.
47. Busby, W.H., D.G. Klapper, and D.R. Clemmons. 1988. Purification of a 31000 dalton insulin like growth factor binding protein from human amniotic fluid. J. Biol. Chem. 263:14203-14210.
48. Jones, J., T. Prevette, A. Gockerman, and D. Clemmons. 1996. Ligand occupancy of the aVb3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor 1. Proc. Natl. Acad. Sci. USA. 93:2482-2487.
49. Gockerman, A., J. Jones, T. Prevette, and D. Clemmons. 1995. Insulin-like growth factor binding protein-2 inhibits smooth muscle cell migration response to IGF-I. Endocrinology. 136:4168-4173.
50. Vuori, K., and E. Ruoslahti. 1994. Association of insulin receptor substrate-1 with integrins. Science (Wash. DC). 266:1576-1578
51. Schlaepfer, D.D., S.K. Hanks, T. Hunter, and P. van der Geer. 1994. Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (Lond.). 372:786-791.
52. Chen, Q., M.S. Kinch, T.H. Lin, K. Burridge, and R.L. Juliano. 1994. Integrin-mediated cell adhesion activates mitogen-activated protein kinases. J. Biol. Chem. 269:26602-26605.
53. Morino, N., T. Minura, K. Hamasaki, T. Tobe, K. Jeki, K. Kikuchi, K. Takehara, T. Kadowaki, Y. Yashaki, and Y. Nojima. 1995. Matrix/integrin interaction activates the mitogen-activated protein kinase, p44erk-1 and p42erk-2. J. Biol. Chem. 270:269-273.
54. Obberghen, E.V. 1994. Signalling through the insulin receptor and the insulin-like growth faclor-I receptor. Diabetologia. 37(Suppl. 2):S125-S134.
55. Plopper, G.E., H.P. McNamee, L.E. Dike, K. Bojanowski, and D.E. Ingber. 1995. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol. Biol. Cell. 6: 349-1356.
56. Zhang, Z., K. Vuori, H.-G. Wang, J.C. Reed, and E Ruoslahti. 1996. Integrin activation by R-ras. Cell 85:61-69.
57. Schwartz, M., and D. Ingber. 1994. Integrating with integrins. Mol. Biol. Cell. 5:389-393.